[Federal Register Volume 76, Number 239 (Tuesday, December 13, 2011)]
[Notices]
[Page 77479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-31935]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket T-6-2011]
Foreign-Trade Zone 7--Mayaguez, PR; Application for Temporary/
Interim Manufacturing Authority; Baxter Healthcare of PR
(Pharmaceutical and Nutritional Intravenous Bags and Administration
Sets); Aibonito and Jayuya, PR
An application has been submitted to the Executive Secretary of the
Foreign-Trade Zones Board (the Board) by the Puerto Rico Industrial
Development Company, grantee of FTZ 7, requesting temporary/interim
manufacturing (T/IM) authority at two sites within FTZ 7 at the Baxter
Healthcare of Puerto Rico (Baxter) facilities, located in Aibonito and
Jayuya, Puerto Rico. The application was filed on December 6, 2011.
The Baxter facilities (200 million unit capacity) are used for the
manufacture of pharmaceutical and nutritional intravenous (I.V.) bags
and related components. Under T/IM procedures, Baxter has requested
authority to produce filled pharmaceutical and nutritional I.V. bags
(HTSUS 3004.20, 3004.40, 3004.50, 3004.90--duty rate: free) and I.V.
administration sets and their components (HTSUS 9018.90--duty rate:
free). Foreign materials that would be used in production (representing
9% of the value of the finished product) include: Foil pouches (HTSUS
3923.29), ABS resin (HTSUS 3903.30), L-tryptophan (HTSUS 2933.99),
glutamic acid (HTSUS 2922.42), N-Acetyl-L-Tyrosine (HTSUS 2924.29) and
L-Lysine-Acetate (HTSUS 2922.41) (duty rates range: 3-6.5%). T/IM
authority could be granted for a period of up to two years.
FTZ procedures could exempt Baxter from customs duty payments on
the foreign components used in export production. The company
anticipates that some 22 percent of the facilities' shipments of I.V.
administration sets and components will be exported. On its domestic
sales, Baxter would be able to choose the duty rate during customs
entry procedures that applies to filled I.V. products and
administration sets (duty rate: free) for the foreign inputs noted
above. Baxter could also be exempt from duty payments on foreign
materials that become scrap or waste during the production process.
In accordance with the Board's regulations, Diane Finver of the FTZ
Staff is designated examiner to evaluate and analyze the facts and
information presented in the application and case record and to report
findings and recommendations pursuant to Board Orders 1347 and 1480.
Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at the following address: Office of the Executive Secretary,
Foreign-Trade Zones Board, U.S. Department of Commerce, Room 2111, 1401
Constitution Ave. NW., Washington, DC 20230. The closing period for
their receipt is January 12, 2012.
Baxter has also submitted a request to the FTZ Board for FTZ
manufacturing authority beyond a two-year period. It should be noted
that the request for extended authority is being docketed separately
and will be processed as a distinct proceeding. Any party wishing to
submit comments for consideration regarding the request for extended
authority would need to submit such comments pursuant to the separate
notice that will be published for that request.
A copy of the application will be available for public inspection
at the Office of the Foreign-Trade Zones Board's Executive Secretary at
the address listed above, and in the ``Reading Room'' section of the
Board's Web site, which is accessible via http://www.trade.gov/ftz. For
further information, contact Diane Finver at [email protected],
(202) 482-1367.
Dated: December 6, 2011.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2011-31935 Filed 12-12-11; 8:45 am]
BILLING CODE P